PherDal Fertility Science

What PherDal Fertility Science does

PherDal Fertility Science is a private US medical device company headquartered in Dixon, Illinois, that manufactures the PherDal Kit — the only FDA-cleared (510(k)) and 100% pre-sterilized at-home intracervical insemination (ICI) kit on the market. The kit comprises three individually wrapped, sterilized IVF-grade needleless syringes and three round-bottom collection cups, validated by three utility patents, and is positioned as a clinical-IUI alternative at under $200 per kit versus $200–$4,000 for IUI and up to $30,000 for IVF. The company serves individuals and couples experiencing infertility (unexplained, secondary, and male factor), LGBTQIA+ family builders, single mothers by choice, and couples trying to conceive without a formal infertility diagnosis.

The underlying technology is mechanical and materials-science based rather than digital: an anatomically designed syringe long enough to deposit sperm at the cervical opening (one inch below IUI), a patented round-bottom collection jar to maximize sample recovery, and IVF-grade sperm-friendly materials claimed to deliver 99% sperm survival versus roughly 20% loss in generic syringes. Sterility is the central differentiator — PherDal is the only at-home kit validated as pathogen-free, addressing what the founder cites as a leading cause of unexplained infertility (bacterial disruption of the vaginal microbiome).

PherDal operates a product-led growth model with revenue from one-time kit purchases (under $200) and ancillary digital products including The Fertility Toolkit online course ($19.99), a free ovulation journal, and an eBook. Distribution is direct-to-consumer via a Shopify storefront on pherdal.com (US-only shipping) plus a telehealth partnership with Wisp that places the kit alongside Proov in medically-guided fertility consultations. The company has 1-10 employees, is founder-led by Dr. Jennifer Hintzsche (Ph.D. in Biology), and was bootstrapped/self-funded through a single $623,150 funding round in December 2022. Notable third-party validation includes TIME's Best Inventions of 2024 and an SXSW Innovation Award.

Name

PherDal Fertility Science

Legal name

PherDal Fertility Science

Website

https://pherdal.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

PherDal Fertility Science manufactures the only FDA-cleared, sterile at-home intracervical insemination kit, serving individuals and couples experiencing infertility, LGBTQIA+ families, single mothers by choice, and male-factor infertility cases via direct-to-consumer e-commerce and telehealth.

Ownership category

akta.pro rank

Product category

At-Home Fertility Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

akta.pro secondary industries

Fertility & Ovulation Products (OTC) (CRABAIAK), Sterilization Consumables & Packaging (Wraps, Pouches, Indicators, Trays/Containers) (HLAHANAC)

Keywords

• At-home insemination kits
• FDA-cleared fertility devices
• Intracervical insemination products
• Fertility treatment supplies
• Medical-grade insemination syringes

Headquarters

HQ city

Dixon

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel

Revenue model

1. PherDal Kit (at-home insemination device): One-time purchase of the PherDal at-home ICI kit, priced at under $200 per kit. Each kit includes 3 sterile syringes and 3 collection cups, providing 3 chances to conceive per cycle. The kit is a single-use sterile medical device sold directly via the company's e-commerce storefront and through telehealth partner Wisp. Additional kits can be purchased for subsequent cycles.
2. The Fertility Toolkit: Track, Time, and Take Control with Dr. Jenn (online course): A digital video course sold for $19.99 (reduced from $99.99, an 80% discount), providing instant access to Dr. Jenn's ovulation tracking methodology. Revenue is recognized as a one-time digital product sale. Supplementary digital products include an Ovulation Journal (free) and Ovulation Tracking eBook ($19.99).

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

Core offering

PherDal Fertility Science manufactures and sells The PherDal Kit, the only FDA-cleared, 100% pre-sterilized at-home intracervical insemination (ICI) kit. Each kit contains three individually wrapped, sterilized needleless insemination syringes and three round-bottom collection cups made from patented IVF-grade, sperm-friendly materials, providing three chances to conceive per cycle. The product is sold directly to consumers via the company's Shopify storefront and through the Wisp telehealth platform as an affordable alternative to clinical IUI and IVF.

Product overview

PherDal Fertility Science offers a suite of fertility support products centered around its flagship FDA-cleared PherDal Kit—the only 100% sterile, patented at-home intracervical insemination (ICI) device. The core kit enables users to perform at-home insemination at a fraction of IUI/IVF costs, with 3 sterile syringes and 3 collection cups providing multiple attempts per cycle. Complementing the device, the company provides educational resources including The Fertility Toolkit online course, a free ovulation journal, and Dr. Jenn's ovulation tracking eBook—all designed to help users understand their cycles and optimize timing for conception. The product ecosystem is positioned as a first-line fertility treatment option before escalating to clinical procedures.

Differentiator

Problem solved

Functional benefit

Products and services

• The PherDal Kit The PherDal Kit is the only FDA-cleared, 100% sterile at-home intracervical insemination (ICI) kit. Each kit contains three patented, individually wrapped and sterilized needleless insemination syringes (the longest on the market) and three round-bottom collection cups made from IVF-grade, sperm-friendly materials. It is sold to individuals and couples seeking an affordable, sterile alternative to clinical IUI, including those with unexplained, secondary, or male factor infertility, LGBTQIA+ prospective parents, and single mothers by choice.
• The Fertility Toolkit: Track, Time, and Take Control with Dr. Jenn An online video course by Dr. Jennifer Hintzsche that teaches scientifically accurate ovulation tracking, LH surge interpretation, and insemination timing. It includes downloadable resources such as an ovulation journal template and fertility-friendly lifestyle guides and is sold as a digital add-on for users of the PherDal Kit.
• Free Ovulation Journal A complimentary ovulation tracking journal template offered by PherDal to help users monitor their fertility window and correctly time at-home insemination.
• Dr. Jenn's Ovulation Tracking eBook An eBook authored by Dr. Jennifer Hintzsche covering ovulation tracking methods to support fertility and improve the chances of conception.

Quantifiable outcome

• 24–30% success rate per cycle for ICI (intracervical insemination) using sterile, lab-quality kits — comparable to clinical IUI
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• WispcoreGTM or Marketing PartnerPherDal is distributed through Wisp's telehealth platform alongside Proov, as part of a fertility services expansion initiative. Wisp is a telehealth company that offers affordable, direct-to-consumer healthcare services. The partnership enables PherDal to reach customers through medically-guided consultations, integrating the kit into fertility treatment recommendations. PherDal's DIY fertility kits ($99–$200) are offered alongside Wisp's telehealth services as an affordable alternative to clinical IUI ($200–$4,000) or IVF (up to $30,000).

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Mosie Baby: Mosie Baby sells at-home intracervical insemination syringes directly to consumers trying to conceive, including LGBTQIA+ families. It is the most direct head-to-head competitor to PherDal in the DTC at-home insemination kit category.
• Stork OTC: Stork OTC is an over-the-counter home conception device (cervical cap insemination) sold online and through retailers. It targets the same 'at-home IUI alternative' use case as PherDal but without PherDal's FDA clearance or sterility claims.
• Natalist: Natalist is a direct-to-consumer fertility and pregnancy brand offering conception-support products, ovulation tests, and prenatal vitamins. It competes for the same preconception customer with a broader product line but no sterile insemination device.

Emerging players

• Proov: Proov sells at-home ovulation and hormone testing kits and is co-distributed with PherDal on the Wisp telehealth platform. Overlap is partial — Proov focuses on cycle diagnostics while PherDal focuses on insemination hardware — but they share the same at-home fertility consumer.

Broad incumbents

• Frida (Fertility line): Frida is a scaled consumer wellness brand that has expanded into fertility and postpartum. Its brand reach and retail distribution make it a credible entrant or acquirer of at-home insemination SKUs that could compete with PherDal.
• Modern Fertility: Modern Fertility (acquired by Ro) sells DTC hormone and fertility testing for women and serves a highly overlapping preconception customer. It competes for the same attention and wallet but in diagnostics rather than insemination devices.
• Maven Clinic: Maven Clinic is a virtual care platform for women's and family health, including fertility and preconception. It competes for the same customer acquisition moment and could either partner with or displace PherDal in the clinical recommendation layer.
• Kindbody: Kindbody operates a national network of fertility clinics and employee benefit programs. It represents both a competitive threat (clinical IUI/IVF) and a potential channel partner that could refer patients to PherDal as a lower-cost first step.

Others

• Wisp: Wisp is PherDal's telehealth distribution partner, offering PherDal alongside Proov through its fertility services. It is adjacent rather than competitive, providing the medical-channel funnel that PherDal relies on for credibility-driven conversions.
• Carrot Fertility: Carrot Fertility provides employer-sponsored fertility benefits covering IUI, IVF, and adjacent services. As a payer-side platform, it influences which products employees are funneled toward and could become a high-leverage channel partner for PherDal.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@pherdalfertilityscience
• Facebookfacebook.com/PherDal
• LinkedInlinkedin.com/company/pherdal
• Instagraminstagram.com/pherdal_science
• Pinterestpinterest.com/PHERDAL
• TikToktiktok.com/@pherdal_science?

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PherDal Fertility Science